title: Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.
authors.affiliation: University of California, San Francisco, and VA Medical Center, San Francisco, California, USA. gayecunnane@hotmail.com
authors.forename: Gaye
authors.initials: G
authors.lastname: Cunnane
authors.forename: Martha
authors.initials: M
authors.lastname: Warnock
authors.forename: Kenneth H
authors.initials: KH
authors.lastname: Fye
authors.forename: David I
authors.initials: DI
authors.lastname: Daikh
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D013902:Radiography, Thoracic; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D012218:Rheumatoid Nodule / Q000139:chemically induced* / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000077339:Leflunomide; D000068800:Etanercept